Latest News about CERE
Recent news which mentions CERE
From Benzinga
From Benzinga
From Benzinga
Analyst Expectations for Cerevel Therapeutics Hldg's Future
March 09, 2023
Tickers
CERE
From Benzinga
Why Reata Pharmaceuticals Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket
March 01, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 23, 2023
February 23, 2023
From Benzinga
Why Quoin Pharmaceuticals Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
February 22, 2023
From Benzinga
Analyst Views Karuna Therapeutics' New Licensing Deal 'As Intriguing'
February 03, 2023
From Benzinga
Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
December 19, 2022
From Benzinga
Data Shows Cerevel's Emraclidine Does Not Induce High Blood Pressure In Schizophrenia Patients
December 19, 2022
Tickers
CERE
From Benzinga
Madrigal Pharmaceuticals, Cerevel Therapeutics And Some Other Big Stocks Moving Higher On Monday
December 19, 2022
From Benzinga
What 8 Analyst Ratings Have To Say About Cerevel Therapeutics Hldg
December 06, 2022
Tickers
CERE
From Benzinga
What 8 Analyst Ratings Have To Say About Cerevel Therapeutics Hldg
November 09, 2022
Tickers
CERE
From Benzinga
Tyson Foods To $61? Plus Needham Slashes PT On This Stock By 33%
November 09, 2022
From Benzinga
Why Cerevel Therapeutics Holdings Shares Are Nosediving
November 08, 2022
Tickers
CERE
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
November 01, 2022
From Benzinga
What 8 Analyst Ratings Have To Say About Cerevel Therapeutics Hldg
October 20, 2022
Tickers
CERE
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 20, 2022
October 20, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2022
September 29, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 26, 2022
September 26, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 13, 2022
September 13, 2022
From Benzinga
Mizuho Is Bullish On This Schizophrenia-Focused Stock, Read Why
August 23, 2022
From Benzinga
From Benzinga
From Benzinga
Here's Why Cerevel Therapeutics Stock Is Getting Hammered Today
August 11, 2022
Tickers
CERE
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
|
|
|
|
|
|